TACE Plus Ivonescimab for Unresectable Non-Metastatic HCC

Clinical trial NCT06990620 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06990620
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)

Start date: 2025-06-01
Primary completion: 2027-06-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.